Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs
GlaxoSmithKline (GSK) Denies Plans to Spin Off Consumer Health-Care Division
Sanofi Pasteur (SASY.PA) Abandons Antibiotics Deal With South San Francisco's KaloBios Pharmaceuticals, Inc. (KBIO)
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share
Pfizer Inc. (PFE)'s Need For A Deal Looms Larger As Second Quarter Profits Sinks 79 Percent
Four Biotech-Related Companies Sign Up For Start-Up NY Program, New Jobs Created
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount
Quark Pharmaceuticals Inc. Reports Favorable Data From Phase 2 Clinical Trial Evaluating Investigational siRNA QPI-1002
Polaris Names Ex-Pfizer Inc. (PFE) Exec As Area’s First Female VC Partner
GlaxoSmithKline (GSK) May Separate Businesses
Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing
FDA Rejects Redwood City's AcelRx Pharmaceuticals (ACRX) Painkiller Dispensing Device; Stock Plunges -34.35% At 9:37AM ET
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX)
Confirmed: Reckitt Benckiser Plc (RB.L) To Spin Off Heroin Treatment Business
See All News >
//-->